rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
2010-12-3
|
pubmed:abstractText |
Pre-procedural platelet reactivity (PR) in Korean patients may be greater because the CYP2C19*2 and *3 variant alleles are more common in Korean patients than in Caucasians. We investigated the level of PR and the prevalence of high post-clopidogrel platelet reactivity (HPPR) after a routine loading dose (LD) of clopidogrel in Korean patients.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1880-3873
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
27
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1122-31
|
pubmed:meshHeading |
pubmed-meshheading:20724801-Acute Coronary Syndrome,
pubmed-meshheading:20724801-Aged,
pubmed-meshheading:20724801-Angioplasty, Balloon, Coronary,
pubmed-meshheading:20724801-Aryl Hydrocarbon Hydroxylases,
pubmed-meshheading:20724801-Female,
pubmed-meshheading:20724801-Humans,
pubmed-meshheading:20724801-Male,
pubmed-meshheading:20724801-Middle Aged,
pubmed-meshheading:20724801-Mutation,
pubmed-meshheading:20724801-Platelet Activation,
pubmed-meshheading:20724801-Platelet Aggregation,
pubmed-meshheading:20724801-Platelet Aggregation Inhibitors,
pubmed-meshheading:20724801-Polymorphism, Genetic,
pubmed-meshheading:20724801-Republic of Korea,
pubmed-meshheading:20724801-Risk Factors,
pubmed-meshheading:20724801-Ticlopidine,
pubmed-meshheading:20724801-Treatment Outcome
|
pubmed:year |
2010
|
pubmed:articleTitle |
Pre-procedural platelet reactivity after clopidogrel loading in korean patients undergoing scheduled percutaneous coronary intervention.
|
pubmed:affiliation |
Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, Korea.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|